I found us a mid-range biotech company that is trading at a bargain price.
The stock is trading at $0.43, but after a recent pullback I expect we will see a move that will break above it's 52-week high in the short term.
The company is oversold right now, and looks like an excellent short term 'bottom-bouncer' with volume swelling over the last few trading days.
Our pick is a biotech company that is seeking FDA approval on a Probiotic supplement.
Probiotic supplements are the latest advancements made to digestive health, usually taken as a supplement to not only aid digestion, but also to prevent and cure numerous gastrointestinal diseases.
Probiotics are currently a $15 Billion dollar chunk of the supplement market, which is expected to reach over $22 Million by 2013!
If the company gets the FDA approval they are seeking, they would be the only company in the world with an FDA approved probiotic supplement.
This would instantly make them a market leader in a $22 Billion dollar sector!
With the stock currently trading at $0.43, the company has a $13 Million dollar market cap and looks like an excellent trade for us at the current price.
No comments:
Post a Comment